Tag: pathology coding

Labs Have Questions about Prostate Biopsy Policy

By Joseph Burns, from the Volume XIX No. 13 - September 17, 2012 issue

CEO SUMMARY: How will pathology laboratories respond to the publication of revised policies in how laboratories should file Medicare Part B claims for prostate biopsies? Not only will there be a sharp drop in the reimbursement paid for a 12-core prostate biopsy, but labs may be at increased risk of a RAC audit, along with

View Article

Medicare Carrier Plans to Reject Molecular Claims

By Robert Michel, from the Volume XVIII No. 15 - November 7, 2011 issue

CEO SUMMARY: In September, Palmetto, a Medicare carrier serving California and seven other states, made public two draft local coverage determinations (LCDs) that revamp its coverage guidelines for molecular diagnostic tests (MDT) and laboratory-developed tests (LDT). All labs submitting claims to Palmetto would need to apply to Palmetto for each MDT or LDT it plans

View Article

Tag: pathology coding

Enter Your Login Credentials